Blueprint Medicines Corp (BPMC)
90.46
+0.13
(+0.14%)
USD |
NASDAQ |
Dec 24, 16:00
Blueprint Medicines Profit Margin (Quarterly): -43.90% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 37.71% |
| PTC Therapeutics Inc | -54.20% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| SpringWorks Therapeutics Inc | -108.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.13% |
| Return on Assets | -11.44% |
| Return on Invested Capital | -23.14% |
| Gross Profit Margin (Quarterly) | 98.49% |
| Operating Margin (Quarterly) | -38.21% |
| Return on Net Operating Assets | -67.45% |